Term insurance is the right answer for most households.

The product taxonomy

Term life provides death-benefit coverage for a defined term (10, 15, 20, 25, 30, sometimes 40 years). Premiums are level for the entire term. No cash value accumulates. If the insured outlives the term, coverage ends and no benefit is paid. The cleanest product economically: pure mortality coverage at actuarial cost plus carrier expenses and modest profit margin.

Whole life provides permanent coverage (until death, assuming premiums are paid). Premiums are level for life. A guaranteed cash-value account accumulates inside the policy, growing tax-deferred. The policy can be borrowed against. More expensive than term per dollar of coverage, often 8–15× in the early years.

Universal life (UL) provides permanent coverage with flexible premiums and a cash-value account that earns a credited rate (set by the carrier, with floor and cap). Premiums and death benefit can be adjusted within limits.

Indexed universal life (IUL) is a UL variant where the cash-value crediting rate is linked to a stock-market index (typically the S&P 500), capped on the upside and floored at zero. Marketed as participation in market upside without market downside; the participation cap and the policy charges materially limit realised returns in practice.

Variable universal life (VUL) is a UL variant where the cash-value account is invested in sub-accounts similar to mutual funds. Higher upside potential, real downside risk to cash value (and potentially to coverage if cash value depletes).

The actuarial-fairness comparison

For the same insured and the same death benefit, a permanent product’s premium consists of three components: the cost of insurance (the actuarially fair mortality charge), the cost of policy expenses (carrier overhead and agent commission), and the savings deposit that builds cash value. The cost-of-insurance component is approximately equal to the cost of a year of term insurance at the same age and health rating. The savings-deposit component is what buyers think they are getting as “value” in a permanent policy.

The crucial finding from actuarial-fairness analysis: the savings-deposit component of a whole-life or universal-life premium typically earns a long-run real return of 1–3 % net of policy charges. This is meaningfully below the long-run real return on a balanced index portfolio (4–6 % real) and below the real return on long-tenor government bonds in most market environments. The “buy term and invest the difference” recommendation, popularised in the 1970s by figures like A.L. Williams and amplified by personal-finance authors since, follows directly: take the cheaper term coverage, invest the premium difference yourself in low-cost index funds, and end up materially wealthier over the long run.

Worked premium comparison

Insured: 32-year-old male non-smoker, healthy. Coverage requested: $1,000,000.

• 20-year level term: approximately $480/year for the entire 20-year period (rates expire at end of term).
• Whole life: approximately $11,500/year level for life (premiums never increase, coverage permanent, cash value accumulates).
• Indexed universal life: approximately $7,500–$10,500/year (variable on illustration; actual long-run cost depends on credited rate vs cap and policy charges).

The annual premium difference between term and whole life is approximately $11,000. Invested over 20 years at a 6 % nominal real return, that $11,000 annual investment grows to approximately $405,000. The whole-life cash value at year 20 is typically $250,000–$320,000 depending on dividend performance. The buy-term-and-invest delta is roughly $90,000–$155,000 in the buyer’s favour over a 20-year horizon, with continued divergence afterward.

For most working-age households, this is the entire argument. Term insurance + diversified investment outperforms whole-life as a wealth-accumulation strategy by a substantial margin, while providing equivalent or greater death-benefit coverage during the dependency years.

When whole life makes economic sense

Whole life is not always wrong. The narrow circumstances where it is genuinely defensible:

• Estate planning for high-net-worth households: where the death benefit is positioned to provide liquidity for federal estate tax (currently triggering above $13.6M per individual as of 2026 under the Tax Cuts and Jobs Act sunset; subject to legislative change). Properly structured (e.g., owned by an Irrevocable Life Insurance Trust), the death benefit passes outside the taxable estate and provides cash to settle estate taxes without forcing asset sales. This is a sophisticated planning use, typically engaged by households with $5M+ net worth working with estate-planning attorneys.
• Special-needs planning: where the household needs to provide lifetime financial support for a special-needs beneficiary, the permanent guarantee of coverage matters more than the cost-efficiency of term. Often paired with a special-needs trust as beneficiary.
• Highly disciplined buy-term-and-cannot-invest scenarios: rare but real. Some buyers know that they cannot consistently invest the premium difference (due to discipline, life circumstances, or other factors). For these buyers, the forced-savings nature of whole-life premiums is genuinely valuable, even at sub-optimal returns. The argument is behavioural, not actuarial.

For the typical working-age household with dependents, none of these conditions apply. Term is the right answer.

The IUL marketing trap

Indexed universal life is heavily marketed as “market upside without market downside.” The illustrations agents present typically show 6–7 % annualised crediting rates over multi-decade horizons, producing apparently large cash values at retirement. The mathematical reality is meaningfully less attractive:

• Cap rates: most IUL contracts cap upside at 9–13 % per year. In years when the index returns 30 %, the contract credits the cap, not the index.
• Participation rates: some contracts credit only a fraction of the index return up to the cap.
• Floor rates: usually 0 %. In years when the index returns −20 %, the contract credits 0 %, but policy charges (mortality, expenses) continue to be deducted from cash value.
• Carrier discretion: caps, participation rates, and credited rates can be adjusted by the carrier in many products. The illustrated rate at sale is rarely sustained over the policy life.

The realised return on most IUL policies over multi-decade holding periods is closer to 3–5 % real, net of charges. Below the long-run real return on equities, comparable to the long-run return on intermediate-tenor bonds, but with materially less liquidity, transparency, and tax efficiency than a brokerage-account index fund. The marketing case rarely survives careful analysis. SEC and state insurance regulators have flagged IUL marketing as a recurring concern; the AICPA has published cautionary practice notes on its use in financial planning.

The conversion-rider feature

One useful feature on quality term policies: a conversion rider that allows the insured to convert the term policy to a permanent product (whole life or universal life from the same carrier) without re-underwriting. The rider is typically valid through some defined window (often the first 10–15 years of the term) and allows insureds whose health declines to retain coverage that would otherwise become uninsurable.

For the typical buyer who will let the term expire and self-insure thereafter, the conversion rider is not relevant. For buyers concerned about insurability later in life or who want optionality on permanent coverage if circumstances change, the rider is worth seeking out at policy origination. It typically adds 0–5 % to term premiums, sometimes nothing.